Investigational Site Number 124013

Cambridge N3H 3R8

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Hypercholesterolemia

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed